Sherbrooke Park Advisers’s Recursion Pharmaceuticals RXRX Stock Holding History

Sherbrooke Park Advisers’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$57.5K	Buy
2025 Q1	–	Sell
2024 Q4	$177K	Buy
2024 Q3	–	Sell
2024 Q2	$251K	Buy